For many people living with depression, the path to feeling better is not always straightforward. Antidepressant medications and therapy help many individuals, and while they are the standard treatment protocol for MDD, many struggle despite trying multiple treatment options. This is often referred to as treatment-resistant depression, and it can be incredibly frustrating and discouraging for those experiencing it.
Over the past decade, transcranial magnetic stimulation (TMS) has become a powerful treatment option for individuals whose depression has not improved with medication and therapy. At practices like Goolsby and Associates, TMS has helped many patients find meaningful relief without the need for additional medications or invasive procedures.
Now, an emerging approach called accelerated TMS (aTMS) is gaining attention. This innovative protocol delivers the same type of brain stimulation used in traditional TMS but in a more condensed timeframe. Early research suggests that accelerated TMS may offer faster symptom relief in some patients.
Understanding what accelerated TMS is and how it differs from traditional treatment can help individuals exploring options for treatment-resistant depression make informed decisions about their care.
Understanding How TMS Works
Transcranial magnetic stimulation is a non-invasive treatment that uses gentle magnetic pulses to stimulate specific areas of the brain involved in mood regulation. In people with depression, certain regions of the brain often show decreased activity.
TMS works by delivering targeted magnetic pulses through a small coil placed against the scalp. These pulses stimulate brain nerve cells and promote healthier patterns of activity in mood-regulating networks.
Unlike medications that circulate throughout the body, TMS works directly on the brain circuits associated with depression. This targeted approach allows many patients to experience improvement without the systemic side effects that sometimes occur with antidepressant medications.
At Goolsby and Associates, TMS treatments are performed in a comfortable outpatient setting. Patients remain awake during the procedure and can return to their normal daily activities immediately afterward.
Traditional TMS Treatment
Standard TMS has a well-established treatment schedule. Patients typically receive one treatment session per day, five days a week, for seven weeks. Sessions at Goolsby and Associates generally last 5 to 30 minutes, depending on the specific protocol.
Many patients begin to notice gradual improvements in mood, energy, and focus over the course of treatment.
However, the traditional schedule requires consistent daily visits for several weeks. For individuals balancing work, family responsibilities, or long travel distances, this commitment can sometimes be challenging.
What Is Accelerated TMS?
Accelerated TMS uses the same technology and principles as traditional TMS but changes the timing and frequency of treatments.
Instead of receiving one session per day over several weeks, accelerated protocols deliver multiple treatment sessions in a single day. These sessions are spaced out with rest periods between them.
The idea behind accelerated TMS is based on emerging research suggesting that more concentrated stimulation over a shorter timeframe may produce faster changes in brain activity. By stimulating mood-related brain circuits more intensively, researchers hope to speed up the process of symptom improvement.
Comparing the Treatment Experience
For patients considering TMS, one of the biggest differences between traditional and accelerated protocols is the treatment timeline.
Traditional TMS gradually spreads treatment over several weeks. This steady schedule allows the brain to respond to repeated stimulation over time, and it has a long track record of safety and effectiveness.
Accelerated TMS compresses the same general treatment concept into a shorter window. Patients may spend several hours at the clinic in a single day receiving multiple sessions, but the overall treatment period is significantly shorter.
Both approaches aim to stimulate the same brain regions involved in mood regulation. The primary distinction is simply how quickly the total treatment dose is delivered.
For individuals experiencing severe depression symptoms, the possibility of completing treatment more quickly can be especially appealing.
What Research Says About Effectiveness
Research on accelerated TMS is still developing, but early findings are promising.
Several clinical studies have shown that accelerated protocols can significantly reduce depression symptoms in individuals with treatment-resistant depression.
Importantly, research comparing accelerated protocols to standard TMS has found similar levels of overall symptom improvement between the two approaches. A meta-analysis of the literature on the efficacy of aTMS compared to standard TMS yields similar results. This suggests that condensed treatment schedules may offer comparable benefits for certain patients.
Researchers are also studying accelerated TMS for other mental health conditions, including anxiety disorders and obsessive-compulsive disorder. While these findings are encouraging, it is important to note that accelerated protocols are still being refined.
FDA Approval and Insurance Coverage
Traditional TMS protocols are FDA-cleared for the treatment of major depressive disorder, particularly for individuals who have not responded to antidepressant medications.
Because accelerated TMS is a newer treatment approach, the specific accelerated schedules themselves are not always included in the original FDA clearance for TMS devices. In many clinical settings, accelerated TMS protocols are considered emerging or investigational treatment strategies even though they use FDA-approved TMS technology.
This distinction can affect insurance coverage.
Many insurance companies currently provide coverage for standard TMS treatment when patients meet certain clinical criteria, such as documented treatment-resistant depression, previous medication trials, and psychotherapy.
Accelerated TMS rarely falls within standard insurance guidelines, depending on the policy and the protocol being used. Some patients may find that insurance covers traditional TMS but not accelerated schedules.
Because coverage policies continue to evolve alongside research, discussing these details with a provider is an important step when considering treatment. It is vital that you speak with your insurance company when considering aTMS, and please do not hesitate to bring your questions to us at Goolsby and Associates. We are here to help answer these questions. We can help our patients understand available options, determine eligibility for TMS treatment, and navigate insurance considerations.
Hope for Patients Seeking New Options
Depression can affect every aspect of life, from relationships and work to physical health and overall well-being. For individuals who have tried multiple medications without success, it can feel as though options are running out.
TMS has already transformed the treatment landscape for many patients with treatment-resistant depression by offering a non-invasive, medication-free alternative. Accelerated TMS represents a next step in the evolution of this technology, with the potential to provide relief more quickly for those who need it most.
While research is ongoing, the growing interest in accelerated protocols reflects an important shift in mental health care: finding ways to deliver effective treatment more efficiently and make recovery more accessible.
For individuals struggling with depression or other mood disorders, speaking with a qualified mental health provider about TMS may be the first step toward discovering a treatment option that finally brings relief. Here at Goolsby and Associates, we will continue to stay at the forefront of these advances, helping our patients explore innovative approaches to healing and long-term mental wellness. Please contact us with any questions you may have about aTMS. We want to see you thrive.